Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Prestige Consumer Healthcare
PBH
Market cap
$3.28B
Overview
Fund Trends
Analyst Outlook
Journalist POV
69.30
USD
-0.91
1.3%
At close
Updated
Feb 27, 4:00 PM EST
Pre-market
After hours
69.30
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-1.3%
5 days
-0.19%
1 month
8.45%
3 months
16.37%
6 months
3.49%
Year to date
13.2%
1 year
-17.23%
5 years
63.91%
10 years
41.72%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
43.8%
Negative
Positive
Neutral
Negative
Neutral
Seeking Alpha
16 days ago
Heartland Opportunistic Value Equity Strategy Q4 2025 Portfolio Activity
One profitable company whose shares we've held for years, and that demonstrates why a focus on shareholder value creation matters in the long run, is Old Republic International. A new mid-cap holding in the quarter was Prestige Consumer Healthcare, whose over-the-counter brands are familiar to many. A multi-year holding that has struggled recently is Watsco, the largest wholesale distributor of HVAC and refrigeration equipment in the United States.
Positive
Zacks Investment Research
17 days ago
PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Up
Prestige Consumer stock ticks higher as Q3 revenues top estimates, but EPS slips 7% and misses forecasts despite margin expansion.
Neutral
Seeking Alpha
24 days ago
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Neutral
Zacks Investment Research
24 days ago
Prestige Consumer Healthcare (PBH) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Prestige Consumer Healthcare (PBH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Negative
Zacks Investment Research
24 days ago
Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.22 per share a year ago.
Neutral
Seeking Alpha
24 days ago
Premium Brands: Setting Expectations For 2026 And Beyond
Premium Brands (PBH:CA) remains a 'Hold' with a price target near $110, reflecting market-like performance expectations into FY 2026. PBH's $10B revenue target hinges on organic growth and disciplined M&A, but high leverage and ongoing Capex constrain aggressive expansion. Organic volume growth outpaced pricing, driving a 19% sales jump, but EBITDA margins remain pressured by elevated beef costs and new plant overhead.
Neutral
GlobeNewsWire
24 days ago
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results
TARRYTOWN, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and nine months ended December 31, 2025.
Positive
Zacks Investment Research
1 month ago
PBH vs. A: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
Neutral
GlobeNewsWire
1 month ago
Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference
TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market.
Positive
Zacks Investment Research
1 month ago
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close